Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807948 · ClinicalTrials.gov registry record · NA
SJM MRI Diagnostic Imaging Registry (IDE)
A NA study of Cardiac Arrhythmia, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 189
- Enrollment target
- 20
- Study locations
NCT02807948: Completed NA study of Cardiac Arrhythmia, sponsored by Abbott Medical Devices.
NCT02807948 is a NA study of Cardiac Arrhythmia that has completed, run by Abbott Medical Devices. The registered enrollment target is 189 participants, roughly in line with the 198-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target. The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02807948, a NA study of Cardiac Arrhythmia, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 189 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is a prospective, non-randomized, multi-center study of subjects implanted with an SJM pacemakers, implantable cardioverter defibrillator (ICD), and cardiac resynchronization therapy (CRT) devices who are clinically indicated for a non-thoracic MRI scan.
Primary Outcome
Based on the ability of the radiologist to read and provide a diagnosis/report.
Conditions Studied
Interventions
- DEVICE Pacemaker, ICD, or CRT device
Study Locations (20)
California
- Quest Imaging - Bakersfield
- Raymond Schaerf, MD - Burbank
- John Muir Medical Center - Concord
- St. Helena Hospital - Deer Park
- Cardiovascular Consultants Heart Center - Fresno
- Newport Diagnostic Center - Newport Beach
- Pro Health Advance Imaging - North Hollywood
- Eisenhower Medical Center - Rancho Mirage
- St. Mary's Medical Center - San Francisco
- Sansum Clinic - Santa Barbara Medical Foundation - Santa Barbara
Florida
- Cardiac Arrhythmia Services - Boca Raton
- Jupiter Medical Center - Jupiter
- Florida Hospital - Orlando
Arizona
- Scottsdale Medical Imaging - Scottsdale
- University of Arizona - Tucson
Colorado
- South Denver Cardiology Associates PC - Littleton
- Medical Center of the Rockies - Loveland
Arkansas
- St. Bernards - Jonesboro
Connecticut
- Hartford Hospital - Hartford
Delaware
- Christiana Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-01-31 |
| Phase | NA |
What the finished NCT02807948 record still lists
NCT02807948 is an interventional study that assigns participants to a tested intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 198-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target.
The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Pacemaker, ICD, or CRT device is the first listed.
NCT02807948 names 20 study sites across 7 states, led by California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT02807948 about?
NCT02807948 is a clinical study titled "SJM MRI Diagnostic Imaging Registry (IDE)". This study is a prospective, non-randomized, multi-center study of subjects implanted with an SJM pacemakers, implantable cardioverter defibrillator (ICD), and cardiac resynchronization therapy (CRT) devices who are clinically indicated for a non-thoracic MRI scan.
What is the current status of trial NCT02807948?
This trial is currently completed. It is a NA study. The enrollment target is 189 participants. The study started on 2016-06. Estimated completion is 2018-01-31.
What conditions does trial NCT02807948 study?
This clinical trial studies the following conditions: Cardiac Arrhythmia.
What interventions are being tested in trial NCT02807948?
The interventions under investigation include: Pacemaker, ICD, or CRT device (DEVICE).
Who is sponsoring clinical trial NCT02807948?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02807948 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02807948's enrollment target sits among peer trials
189 3rd of 12 higher than 10 of 12 other Cardiac Arrhythmia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrhythmia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
ACTIVE NOT RECRUITING · NA
-
AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
COMPLETED · NA
-
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
COMPLETED · NA
-
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
COMPLETED · NA
-
Maestro Handheld Cardiac Monitor Validation
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia